"Legal highs"--toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration.
The easily available "legal highs", which are products containing psychoactive substances, such as cathinones, piperazines and synthetic cannabinoids, are abused by adolescents in Poland and in the world as alternatives to classic drugs, such as amphetamines or marijuana. The majority of these potentially dangerous substances are still legal and they are associated with a risk of severe poisoning or even death, and provide new challenges in clinical and forensic toxicological practice. Investigations in the field of "designer drugs" may be well illustrated by the case of a suicide of a 21-year old male who ingested a specified dose of a preparation called "Amphi-bi-a" that contains bk-MBDB, chemically 2-methylamino-1-(3,4-methylenedioxyphenyl) butan-1-one, which belongs to the cathinone group, as a synthetic euphoric empathogen and psychoactive stimulant that is chemically similar to MDMA. It is one of more common components of "legal highs" examined in Poland and other countries. The documentation of the case includes a clinical assessment of the patient's health status performed during his almost 4-h hospitalization before death, autopsy and histological examinations supported by toxicological findings revealing bk-MBDB at extremely high concentrations (at 20 mg/l in the blood and 33 mg/kg in the liver); hence, this body of evidence contributes to knowledge in the field of "designer drugs". Inventions of designers of new psychoactive xenobiotics, which are much in demand, especially in view of the dynamic Internet marketing, which drums up narcobusiness, must be balanced by a national strategy developed by medical, legal and educational circles in the modern civilized world in order to prevent the spreading of the phenomenon.
Department of Forensic Medicine, Jagiellonian University Medical College, Grzegórzecka 16, Kraków, Poland. msrojek@cyf-kr.edu.pl
Sebastian
S
Rojek
Małgorzata
M
Kłys
Marcin
M
Strona
Martyna
M
Maciów
Karol
K
Kula
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives* / Q000032:analysis / Q000506:poisoning; D002853:Chromatography, Liquid; D015198:Designer Drugs / Q000032:analysis / Q000506:poisoning*; D053593:Forensic Toxicology; D006213:Hallucinogens / Q000032:analysis / Q000506:poisoning*; D006801:Humans; D057230:Limit of Detection; D008099:Liver / Q000737:chemistry; D008297:Male; D021241:Spectrometry, Mass, Electrospray Ionization; D013405:Suicide; D055815:Young Adult
D015198:Designer Drugs; D006213:Hallucinogens; D015104:3,4-Methylenedioxyamphetamine; C544130:2-methylamino-1-(3,4-methylenedioxyphenyl)butan-1-one